about
Development of immunity in early life.QUESTION 2: Does amoxicillin exposure increase the risk of rash in children with acute Epstein-Barr virus infection?Child health in low-resource settings: pathways through UK paediatric training.Complex regional pain syndrome involving the face following snowball injury.Rapid Accurate Identification of Tuberculous Meningitis Among South African Children Using a Novel Clinical Decision Tool.Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma.TLR vaccine adjuvants: closing the stable door before novel influenza strains bolt?Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study.Poison ivy dermatitis.Improving paediatric tuberculosis and HIV clinical record keeping: the use of audit and a structured pro forma in a South African regional level hospital.The Role of Mast Cells in Tuberculosis: Orchestrating Innate Immune Crosstalk?Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.From MDG to SDG: good news for global child health?Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner.Identification of unusual oxysterols and bile acids with 7-oxo or 3β,5α,6β-trihydroxy functions in human plasma by charge-tagging mass spectrometry with multistage fragmentation.Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type IGlobal child health competencies for paediatriciansThe hidden burden of VTEC: an audit of daycare exclusion practiceMetabolism of Non-Enzymatically Derived Oxysterols: Clues from sterol metabolic disordersHuman mast cells exhibit an individualized pattern of antimicrobial responsesThe jigsaw puzzle of chronic non-bacterial osteomyelitis: are anti-IL17 therapies the next piece?Mycobacterium tuberculosis Joyrides Alveolar Macrophages into the Pulmonary Interstitium
P50
Q38454331-130DCA56-900F-487E-A2BA-43634C34CCD1Q38740377-916D5D1B-9987-4473-BEE5-8B2C0964ECE7Q39026127-80238C5F-4A1B-4B47-87E3-74FE3EF8745DQ39124130-B0AF1DB0-0E6B-4139-AE00-15E1C047D20DQ40094732-4F2BC3F6-CE5A-48B6-919B-08EF76752162Q40249819-BE000EEE-137B-4D40-913A-9385A35BAD98Q41120120-1BD91607-BD93-445C-9656-9AD227784FC1Q42248235-006075AB-9B1F-4A8E-8950-BEE99A06ABD6Q46131258-F4EFEECB-628A-4C07-9570-6C474B70FDF4Q46495000-16590240-6B27-4C83-9E09-78BC06162365Q47130424-64D732DB-47BE-4DAD-8E00-B6FEDAA7052CQ50200353-9EB7F532-2C8A-4B77-B29F-DE7104F5D3BAQ50774348-E6F154A8-6C46-4FAA-B01B-B21950FACD3BQ55054457-9B5D5D14-00D4-4ADF-8674-E4EAA8216AADQ55241704-A9948364-E608-4A33-BF59-E118892F5C6AQ64072336-9409113D-8FC3-40EA-9FBC-EE711CE93FADQ85948493-54E402FC-EFFF-4F36-BAC6-B9B0A479E26DQ88223581-4FE9E557-8611-40F7-9078-0667AC2205D4Q90154076-B5EB9D8B-0321-49AA-A593-BB6F633E5085Q90718279-B9233036-9B00-4A80-940D-92E511772F4FQ90824212-5B33C502-7481-4723-B946-29ADD2F5EAD7Q91429027-D93DD65F-A076-4E5F-BB21-409F765B8761
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anu Goenka
@ast
Anu Goenka
@en
Anu Goenka
@es
Anu Goenka
@nl
type
label
Anu Goenka
@ast
Anu Goenka
@en
Anu Goenka
@es
Anu Goenka
@nl
prefLabel
Anu Goenka
@ast
Anu Goenka
@en
Anu Goenka
@es
Anu Goenka
@nl
P106
P1153
50061236600
P31
P496
0000-0002-8152-2155